Omega-3 supplementation boosts immunity and helps reduce inflammation among gastrointestinal cancer patients after surgery, new meta-analysis reports. Surgery is the primary treatment for patients with GI cancer often facing complications due to malnutrition, tumor-induced immune suppression, surgical stress, and inflammation. The research, comprising of 623 patients, showed that patients on omega-3s had lower levels of inflammation markers.
The researchers stated: “The results of our study showed that n-3 PUFAs significantly decreased the level of inflammation and increased immune function Thus modulation of immune responses and reduction of inflammatory responses together lessens postoperative hospital stay for GI cancer patients.”